Shionogi and Kyoto University in new phase of psychiatric disorders project

Drug major Shionogi (TYO: 4507) will take its collaboration with Kyoto University into another five years in the hope that it will lead to new treatments for psychiatric disorders.

The Japanese partners initially teamed up in a five-year collaboration in 2013 focusing on drug discovery and medical research for the regeneration of synapses and neuronal function.

With that five-year period now nearing its end, on Monday a new research agreement was announced to continue the project, focused on drug discovery and medical research for the treatment of psychiatric disorders.